immunosuppressive
[대역어] 면역억제제
[용어속성] Term
[용어속성] Term
COVID-19 in Liver Transplant Recipients: A Systematic Review
Review
[키워드] Analysis
article
articles
available data
Complete
conducted
COVID-19
COVID-19 pandemic
Gastrointestinal symptom
General population
heterogeneity
heterogeneous
Humoral response
Immunity
Immunological response
Immunosuppressant
immunosuppressive
literature review
Liver injury
liver transplant
management
MMF
outcome
recipient
recipients
required
review
SARS-CoV-2
SARS-COV-2 infection
solid organ transplantation
Surveillance
TAC
therapy
Transplant
vaccination
vaccine immunogenicity
while
[DOI] 10.3390/jcm10174015 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jcm10174015 PMC 바로가기 [Article Type] Review
Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies
Review
[키워드] ad-hoc
Administered
auto-immune auto-inflammatory disorders
brand
chronic infection
clinical condition
Consequences
contraindication
Coronavirus disease 2019
country
COVID-19
COVID-19 vaccine
COVID-19 vaccines
develop
disease
disorder
eligible
facilitate
force
Health
highest
immune systems
immunosuppressive
Infection
Italian
Italy
modulated
mRNA vaccine
pandemic
Patient
patients
PIDs
position
Primary immunodeficiencies
respond
SARS-CoV-2
secondary immunodeficiencies
sequence
Society
suffered
therapy
vaccination
Vaccine
Vaccines
viral spread
Viral variants
[DOI] 10.3390/biomedicines9091163 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/biomedicines9091163 PMC 바로가기 [Article Type] Review
Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial
고위험 COVID-19 환자의 항바이러스 및 면역조절 인터페론-베타: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] acting
Acute respiratory failure
acutely ill patient
acutely ill patients
addition
Admission
age
allergy
anamnesis
antiretroviral
Antiviral
Antiviral treatment
approach
ARMS
assigned
Asthma
Autoimmune disease
AVPU
being
binding antibody
Blinding
block
blocks
blood pressure
blood sample
bridge
calculated
Care
cartridge
Chemotherapy
chronic kidney diseases
clinical assessment
Clinical Center
clinical centers
Clinical deterioration
clinical monitoring
Clinical sign
conducted
Control
control arm
control group
control patients
Controlled
COVID-19
COVID-19 symptoms
crackles
creatinine
criteria
cytokine
Darmstadt
Day
death
Dementia
determined by
diagnosed
disease
Disease progression
dissemination
dose
Efficacy
EGFR
Elderly patient
element
eligible
Eligible patients
Endpoint
enrolled
enrolment
EudraCT
evaluate
Evidence
evidence of
exclusion criteria
expected
experimental arm
female
following
form
Gender
Germany
Health
heart rate
High-dose
HIV infection
Hospitalized
hospitalized patients
hypersensitivity
ICU
identification number
IFN
IFN-β
IFNβ
immunomodulation
immunomodulatory
immunomodulatory property
immunosuppressive
Impaired
impairing
inclusion criteria
increase in
Infectious disease
Infectious diseases
Informed consent
injected
injection
intensive care unit
interferon
Interferon-beta
investigator
involved
kidney
laboratory-confirmed SARS-CoV-2 infection
Lazzaro Spallanzani
less
level of care
Life expectancy
low-dose
male
management
mechanical ventilation
mild COVID-19 symptom
mild COVID-19 symptoms
multiple sclerosis
Nasopharyngeal swab
nasopharyngeal swabs
National Early Warning Score
NEWS2
non-hospitalized patients
normal range
number
objective
Older
open
Open-label
outcome
oxygen
oxygen saturation
participant
Patient
patient identification
patients
patients treated
PCR
performed
phase
physical
physician
Presence
primary endpoint
proportion
protocol
provide
Psychological
pulse
rales
randomised
randomised controlled trial
randomization
randomization system
Randomized
Randomly
receive
recruitment
reducing
reduction in
Regional
registration date
relapsing
renal function
Respiratory failure
respiratory rate
responsible
resulting
risk
Rome
room air
RT-PCR
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 RT-PCR
score
Secondary objective
Secondary objectives
selected
sequence
severe COVID-19
severe depression
severe disease
specimen
SpO2
Standard of care
status
stratified
Stratified randomization
Study protocol
subcutaneously
subject
supervision
supplemental oxygen
supplementary material
symptomatic
temperature
Toxicity
treat
Treatment
treatment arm
treatment group
Trial
Trial registration
unique
unit
venous
venous blood
Version
vital signs
website
Withdrawal
worsening
written Informed Consent
[DOI] 10.1186/s13063-021-05367-6 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05367-6 PMC 바로가기 [Article Type] Letter
Outpatient Management of COVID-19 With Monoclonal Antibody Therapy in a Young Renal Transplant Patient
Internal Medicine
[키워드] available data
baseline
Care
complex
coronavirus disease
cough
COVID-19
high mortality rate
highlight
Hospitalization
ICU
Immunocompromised patient
Immunosuppression
immunosuppressive
increased risk
infectious complication
mAb
male
mild case
monoclonal antibodies
monoclonal antibody
monotherapy
Mortality
Outpatient
Patient
positive
receiving
recipient
regimen
regimens
renal
Renal transplant
significantly lower
solid organ transplant
symptomatic
tested
therapy
Transplant
treated
[DOI] 10.7759/cureus.17672 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.17672 PMC 바로가기 [Article Type] Internal Medicine
Anterior Scleritis Manifesting After Coronavirus Disease 2019: A Report of Two Cases
코로나바이러스 질병 2019 이후에 나타나는 전방 공막염: 2건의 보고
Case Reports
[키워드] addition
Anterior
Autoimmune diseases
biologic agents
Characteristics
convalescent phase
coronavirus disease
Corticosteroid
COVID-19
Cyclophosphamide
Efficacy
evaluated
eye
immunosuppressive
intravenous
Necrotizing scleritis
ocular
Ophthalmologist
Pain
Patient
patients with COVID-19
Prednisolone
report
respiratory symptom
respond
scleritis
Symptom
systemic symptom
therapy
Treatment
[DOI] 10.1097/ICO.0000000000002795 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1097/ICO.0000000000002795 PMC 바로가기 [Article Type] Case Reports
Racing to immunity: Journey to a COVID-19 vaccine and lessons for the future
면역을 향한 경주: COVID-19 백신을 향한 여정과 미래를 위한 교훈
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Antiviral
Antiviral agents
Clinical findings
clinical testing
coronavirus
Coronavirus infections
COVID-19
COVID-19 drug treatment
COVID-19 pandemic
COVID-19 treatment
COVID-19 treatments
COVID-19 vaccine
COVID-19 vaccine trials
database
Disadvantages
drug treatment
effort
facilitate
global scientific community
highlight
identify
immunosuppressive
Immunosuppressive agents
information
joint
list
location
Novel coronavirus
Pandemics
Prophylactic
response
SARS virus
SARS-CoV-2
Scientific community
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
the WHO
Therapeutics
Trial
Vaccine
Vaccines
variety
virus
[DOI] 10.1111/bcp.14686 PMC 바로가기 [Article Type] Review
[DOI] 10.1111/bcp.14686 PMC 바로가기 [Article Type] Review
ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries
저소득 및 중간 소득 국가에서 COVID-19 관련 점막 진균증의 임상 관리를 위한 ECMM/ISHAM 권장 사항
Article
[키워드] animal
antifungal therapy
Care
Clinical management
clinician
Corticosteroid
corticosteroid therapy
Corticosteroids
country
COVID-19
COVID-19 patient
diabetes
Diabetes Mellitus
diagnosing
Diagnosis
disease
Endothelial cell
Epidemic
European
Factor
Factors
Glucose
glycaemic control
GRP
help
High dose
Human
immunosuppressive
Immunotherapy
increased expression
India
indicated
Infection
management
Misconception
Mucorale
Mucorales
Mucormycosis
mycology
occur
Protein
provide
recommendation
regulated
report
SARS-CoV-2
Society
spore
surgical
the disease
tissues
uncontrolled
[DOI] 10.1111/myc.13335 PMC 바로가기 [Article Type] Article
[DOI] 10.1111/myc.13335 PMC 바로가기 [Article Type] Article
Pathogenesis and treatment of cytokine storm in COVID-19
Article
[키워드] acute respiratory distress syndrome
acute respiratory syndrome
Anakinra
antiviral agent
antiviral immunity
blocker
caused
Clinical course
Clinical findings
Clinical symptoms
Complication
coronavirus
Corticosteroids
COVID-19
cytokine response
Cytokine storm
death
Diagnosis
diagnosis of COVID-19
distress
hyperinflammatory state
IL-1
IL-6 blockers
immunomodulatory drug
immunosuppressive
inhibit SARS-CoV-2
Insufficient
Laboratory tests
main mechanism
Measures
mechanism
organ damage
Pathogenesis
pathogenesis of COVID-19
Patient
persistence
reduce
Replication
resulting
SARS-CoV-2
suggested
syndrome
systemic inflammation
the cytokine storm
Tocilizumab
treated
Treatment
viral clearance
viral infection
[DOI] 10.3906/biy-2105-37 PMC 바로가기 [Article Type] Article
[DOI] 10.3906/biy-2105-37 PMC 바로가기 [Article Type] Article
Recurrent lymphangioleiomyomatosis in a lung allograft with COVID-19: autopsy case report and literature review
Case Report
[키워드] Actin
acute respiratory distress
adjusted
age
Allograft
Autopsy
bilateral lungs
biopsy
Case report
Cell
cellular
changes in
characteristic
chest imaging
Clinical course
cough
COVID-19
Cystic lung disease
diagnosed
Diagnosis
Diffuse alveolar damage
discharged
disease
effective
fatigue
female
foci
gastrointestinal hemorrhage
GRADE
HMB-45
Hospital stay
immunosuppressive
literature review
lung
Lung diseases
lung transplant
lung transplantation
Lymphangioleiomyomatosis
Mild
outcome
pathology
Patient
positive
proliferation
Recurrent
regimen
rejection
Respiratory failure
severe COVID-19
Shortness of breath
syndrome
transbronchial
Treatment
viral infection
was performed
[DOI] 10.1186/s42047-021-00095-2 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1186/s42047-021-00095-2 PMC 바로가기 [Article Type] Case Report